Akynzeo Capsule
RxNorm Crosswalk NDC 69639-101

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Akynzeo (NDC 69639-101) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 6 unique RxNorm concepts. By anchoring Helsinn Therapeutics (u.s.), Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCD
Netupitant 300 mg / palonosetron 0.5 mg Oral Capsule
PSN
Akynzeo 300 mg / 0.5 mg Oral Capsule
SCD
Fosnetupitant 235 mg / palonosetron 0.25 mg Injection
PSN
Akynzeo 235 mg / 0.25 mg Injection
SCD
20 mL fosnetupitant 11.75 mg/ML / palonosetron 0.0125 mg/ML Injection
PSN
Akynzeo 235 mg / 0.25 mg in 20 mL Injection
SCDPrescribable
Featured Concept

netupitant 300 MG / palonosetron 0.5 MG Oral Capsule
(RxCUI 1552343)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Mapped Terms
PSNPrescribable
netupitant 300 MG / palonosetron 0.5 MG Oral Capsule
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
SYPrescribable
netupitant 300 MG / palonosetron 0.5 MG (as palonosetron hydrochloride 0.56 MG) Oral Capsule
Synonym
Synonym of another TTY, given for clarity.
PSNPrescribable
Featured Concept

Akynzeo 300 MG / 0.5 MG Oral Capsule
(RxCUI 1552349)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Mapped Terms
SBDPrescribable
netupitant 300 MG / palonosetron 0.5 MG Oral Capsule [Akynzeo]
Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
SYPrescribable
Akynzeo (netupitant 300 MG / palonosetron 0.5 MG (palonosetron hydrochloride 0.56 MG)) Oral Capsule
Synonym
Synonym of another TTY, given for clarity.
SYPrescribable
Akynzeo (netupitant 300 MG / palonosetron 0.5) MG Oral Capsule
Synonym
Synonym of another TTY, given for clarity.
SCDPrescribable
Featured Concept

fosnetupitant 235 MG / palonosetron 0.25 MG Injection
(RxCUI 2044429)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Mapped Terms
PSNPrescribable
fosnetupitant 235 MG / palonosetron 0.25 MG Injection
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
PSNPrescribable
Featured Concept

Akynzeo 235 MG / 0.25 MG Injection
(RxCUI 2044431)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Mapped Terms
SBDPrescribable
fosnetupitant 235 MG / palonosetron 0.25 MG Injection [Akynzeo]
Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
SYPrescribable
Akynzeo (fosnetupitant 235 MG / palonosetron 0.25 MG) Injection
Synonym
Synonym of another TTY, given for clarity.
SCDPrescribable
Featured Concept

20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection
(RxCUI 2374366)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Mapped Terms
PSNPrescribable
fosnetupitant 235 MG / palonosetron 0.25 MG in 20 ML Injection
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
SYPrescribable
fosnetupitant 235 MG (equivalent to fosnetupitant chloride HCl 260 MG) / palonosetron 0.25 MG (equivalent to palonosetron HCl 28 MG) per 20 ML Injection
Synonym
Synonym of another TTY, given for clarity.
SYPrescribable
fosnetupitant 235 MG / palonosetron 0.25 MG per 20 ML Injection
Synonym
Synonym of another TTY, given for clarity.
PSNPrescribable
Featured Concept

Akynzeo 235 MG / 0.25 MG in 20 ML Injection
(RxCUI 2374368)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Mapped Terms
SBDPrescribable
20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection [Akynzeo]
Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
SYPrescribable
Akynzeo (fosnetupitant 235 MG (equivalent to fosnetupitant chloride HCl 260 MG) / palonosetron 0.25 MG (equivalent to palonosetron HCl 28 MG)) per 20 ML Injection
Synonym
Synonym of another TTY, given for clarity.

Understanding RxNorm Mapping for Akynzeo

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 69639-101 to RxCUI 1552343, 1552349, 2044429, 2044431, 2374366, 2374368, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.

* Please review the full disclaimer at the bottom of this page.